Please use this identifier to cite or link to this item: https://accedacris.ulpgc.es/handle/10553/137156
DC FieldValueLanguage
dc.contributor.authorIborra, M.en_US
dc.contributor.authorBotella, B.en_US
dc.contributor.authorMartín-Arranz, M.D.en_US
dc.contributor.authorCeballos Santos, Daniel Sebastiánen_US
dc.date.accessioned2025-04-22T13:41:40Z-
dc.date.available2025-04-22T13:41:40Z-
dc.date.issued2025en_US
dc.identifier.urihttps://accedacris.ulpgc.es/handle/10553/137156-
dc.languageengen_US
dc.publisherOxford University Pressen_US
dc.sourceEuropean Crohn’s and Colitis Organization / #P0890: jjae190.1064, pp. 1685-1686 (Febrero 2025)en_US
dc.subject32 Ciencias médicasen_US
dc.subject320503 Gastroenterologíaen_US
dc.titleReal-World Outcomes of Upadacitinib in Crohn’s Disease: Insights from ENEIDA databaseen_US
dc.typeinfo:eu-repo/semantics/conferenceObjecten_US
dc.typeConferenceObjecten_US
dc.relation.conference20th European Crohn’s and Colitis Organization Inflammatory Bowel Diseasesen_US
dc.description.lastpage1686en_US
dc.description.firstpage1685en_US
dc.investigacionCiencias de la Saluden_US
dc.type2Póster de congresosen_US
dc.description.numberofpages2en_US
dc.utils.revisionen_US
dc.date.coverdateFebrero 2025en_US
dc.identifier.ulpgcen_US
dc.contributor.buulpgcBU-MEDen_US
dc.contributor.buulpgcBU-MEDen_US
dc.contributor.buulpgcBU-MEDen_US
dc.contributor.buulpgcBU-MEDen_US
item.fulltextSin texto completo-
item.grantfulltextnone-
crisitem.author.deptDepartamento de Ciencias Médicas y Quirúrgicas-
crisitem.author.orcid0000-0003-2384-4524-
crisitem.author.fullNameCeballos Santos, Daniel Sebastián-
Appears in Collections:Póster de congreso
Show simple item record

Google ScholarTM

Check


Share



Export metadata



Items in accedaCRIS are protected by copyright, with all rights reserved, unless otherwise indicated.